Entries by aaron

CanTranscutaneous vagal nerve stimulation regulate gastrointestinal disorders?

Imbalanced autonomic function, characterized by reduced vagal activity and sympathetic dominance, is increasingly recognized in various gastrointestinal (GI) disorders. The vagus nerve, a key component of the parasympathetic nervous system, plays a critical role in regulating upper GI motility, inflammation, and pain perception. Transcutaneous vagal nerve stimulation (tVNS) offers a non-invasive method to modulate vagal […]

Breastfeeding Linked to Lower Risk of Early Puberty in Children, reports research

Breastfeeding within the first 4 to 6 months of life has been identified by researchers as being associated with a reduced risk of central precocious puberty (CPP) in children of both genders. CPP is the condition of early onset of puberty at an unnatural age, and it has been on the rise globally, triggering concerns […]

Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg

New Delhi: Sun Pharma has received approval from the Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), to conduct a Phase IV clinical trial of Esomeprazole Dual Release Gastro-resistant Tablets 80 mg, based on its revised study protocol. According to the minutes of the 12th/25 SEC (Gastroenterology & Hepatology) meeting held […]

Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCI

New Delhi: The Pharmacy Council of India (PCI) has issued a final reminder to pharmacy institutions seeking approval under Section 12 for the 2025-26 academic session, directing them to submit complete additional information between August 26 and August 31, 2025. The Council noted that despite repeated opportunities, some institutions have failed to provide the required […]

Bombay HC Grants Conditional Bail to Pharma Manager in Rs 1.25 Crore Suspected Mephedrone Case

Aurangabad: A 57-year old environment, safety, and health manager at a multinational pharmaceutical company has been granted conditional bail by the Bombay High Court, in a high-profile suspected mephedrone seizure case. Justice Sanjay Deshmukh ordered Kishor Pawar’s (57), in Waluj MIDC release on a ₹50,000 personal bond, with strict instructions not to tamper with evidence […]

DNB Surgery course soon at Lok Bandhu hospital Lucknow

Lucknow- In a major development in the field of medical education, Lok Bandhu Raj Narayan Samyukta Chikitsalaya, Lucknow, is soon going to start a new Diplomate of National Board (DNB) course in surgery. For this, the hospital had also received recognition from the National Board of Medical Examination (NBEMS), New Delhi last month, according to […]

Legible Prescriptions a Fundamental Right: Punjab and Haryana HC directs doctors to use capital letters

Chandigarh: Observing that legible medical prescriptions and diagnosis form an essential part of a patient’s right to health under Article 21 of the Constitution, the Punjab and Haryana High Court directed doctors to write prescriptions and diagnosis notes in capital letters until computerisation or typed prescriptions become the norm.  The directive follows a shocking incident where the […]

100 Additional Delhi Hospitals to be added under Ayushman Bharat soon

Delhi Health Minister Dr Pankaj Singh on Thursday announced that the government will add 100 more hospitals under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in the next 10 days. This move will increase the total number of empanelled hospitals in the capital to 165. The updated list is expected to include prominent […]

Health Bulletin 30/August/2025

Here are the top health stories of the day: Doctors, Legal Experts Oppose Lowering Age of Consent Several doctors, psychologists, rights activists and lawyers on Thursday strongly opposed any move to reduce the age of consent from 18 to 16 years, warning that it could adversely impact the social, psychological and physical well-being of adolescents. […]

Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer’s Disease

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once weekly lecanemab-irmb subcutaneous injection (U.S. brand name: LEQEMBI IQLIK, pronounced “I Click”) for maintenance dosing. LEQEMBI IQLIK is a subcutaneous autoinjector (SC-AI) developed by Eisai, containing 360 mg/1.8 mL (200 […]